Article
Modified Recombinant Allergens for Safer Immunotherapy
1 Jan 2006
Abstract excerpt
Molecular cloning and recombinant production of allergens offered new perspectives for the increasing problem of allergies. A variety of preparations are being developed aiming to increase safety and improve efficacy of specific immunotherapy. Recombinant-based approaches are mostly focused on genetic modification of allergens to produce molecules with reduced allergenic activity and conserved antigenicity, i.e....
Topics
Join the communities discussing this publication.